Nacuity Pharmaceuticals, Inc. — Form D

Nacuity Pharmaceuticals, Inc. of FORT WORTH, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-30. The offering totals $30.0M, of which $8.4M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Gerald CagleDirectorFort Worth, TX
Halden ConnerDirectorFort Worth, TX
Emmett Cunningham, Jr.DirectorFort Worth, TX
Rusty KelleyDirectorFort Worth, TX
Robin SteeleDirectorFort Worth, TX
David WohlbergDirectorFort Worth, TX
Benjamin YerxaDirectorFort Worth, TX
Halden ConnerExecutive OfficerFort Worth, TX
Jami KernExecutive OfficerFort Worth, TX
Charles LieserExecutive OfficerFort Worth, TX
Michael WallExecutive OfficerFort Worth, TX
David WohlbergExecutive OfficerFort Worth, TX
Robert RuffoloDirectorBoston, MA
Robin SteelDirectorFort Worth, TX
Isaac Michael BlechDirectorNew York, NY
Charles Michael LieserExecutive OfficerFort Worth, TX
G. Michael Wall, Ph.D.Executive OfficerFort Worth, TX
Dr. Gerald D CagleDirectorFort Worth, TX
David J WohlbergDirectorLos Angeles, CA
William Halden ConnerDirectorFort Worth, TX
William Halden ConnerExecutive OfficerFort Worth, TX
Richard Michael Chin, M.D.DirectorSan Francisco, CA
Sanford J HillsbergDirectorLos Angeles, CA

Other filings by this issuer (5)

FiledFormOfferingSold
2022-01-03D/A$17.4M$11.6M
2021-03-30D$11.0M$3.2M
2017-07-20D/A$10.0M$9.2M
2017-06-27D$10.0M$7.3M
2016-12-08D$2.5M$2.0M

More